Halozyme Therapeutics Inc. (HALO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Halozyme Therapeutics Inc...

    NASDAQ: HALO · Real-Time Price · USD
    75.38
    -0.69 (-0.91%)
    At close: Sep 10, 2025, 11:17 AM

    Halozyme Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 13.65 17.32 38.52 14.04
    PEG Ratio
    		 0.21 0.39 -0.8 0.07
    PS Ratio
    		 5.97 5.88 11.80 12.76
    PB Ratio
    		 16.67 58.18 45.86 28.71
    P/FCF Ratio
    		 12.95 13.06 33.09 18.98
    P/OCF Ratio
    		 12.66 12.55 32.43 18.89
    OCF/S Ratio
    		 0.47 0.47 0.36 0.68
    Debt / Equity Ratio
    		 4.14 17.89 8.87 4.45
    Quick Ratio
    		 6.78 5.50 4.88 7.45
    Current Ratio
    		 7.80 6.64 5.65 7.91
    Asset Turnover
    		 0.49 0.48 0.36 0.40
    Interest Coverage
    		 30.48 17.99 15.79 36.66
    Return on Equity
    		 1.22 3.36 1.19 2.04
    Return on Assets
    		 0.22 0.16 0.11 0.36
    Return on Invested Capital
    		 0.23 0.17 0.13 0.42
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.84 0.77 0.79 0.82
    Net Profit Margin
    		 0.44 0.34 0.31 0.91
    Pretax Profit Margin
    		 0.55 0.42 0.38 0.56
    Operating Profit Margin
    		 0.54 0.41 0.41 0.62
    FCF Margin
    		 0.46 0.45 0.36 0.67
    EBITDA Margin
    		 0.65 0.55 0.48 0.58

    Add to Watchlist